These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2497409)

  • 1. [Costs and benefits in post-surgical chemotherapy and follow-up].
    Zilli L
    Minerva Chir; 1989 Feb; 44(4):813-7. PubMed ID: 2497409
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic effects of "molecular" medicine].
    Riemann JF
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Innovative therapy, early and cost-benefit assessment].
    Dierks C
    Onkologie; 2012; 35 Suppl 2():7. PubMed ID: 22517064
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the subject of neoadjuvant chemotherapy].
    D'Agata A; Dei P; Famigli M; Taffini E; Donati C
    G Ital Oncol; 1990; 10(1-2):35-7. PubMed ID: 2358307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant chemotherapy of cancer: immediate costs and long-term risks].
    Cappelaere P; Demaille A
    Bull Cancer; 1984; 71(4):313-25. PubMed ID: 6498346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why managed care should provide supportive therapies for cancer patients.
    Rubenstein SA
    Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose chemotherapy.
    Selby P
    Chemioterapia; 1987 Jun; 6(2 Suppl):675-7. PubMed ID: 3334660
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy.
    Peroutka JA; Mutnick AH
    Formulary; 1995 Jul; 30(7):394-5, 400-4. PubMed ID: 10151731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escalating costs for cancer chemotherapy.
    Nyman JV; Dorr RT; Hall GR
    Am J Hosp Pharm; 1981 Aug; 38(8):1151-4. PubMed ID: 7270558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
    Orr JW; Orr P; Kern DH
    Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytostatic therapy in cancer--a SBU report].
    Glimelius B; Nygren P; Lamnevik G
    Lakartidningen; 2001 Apr; 98(16):1905-10. PubMed ID: 11370407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined internal medicine-surgical treatment of malignant tumors--from the viewpoint of the internal medicine oncologist].
    Seeber S
    Verh Dtsch Ges Inn Med; 1986; 92():202-6. PubMed ID: 3811510
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental basis of adjuvant chemotherapy.
    Sakurai Y
    Prog Clin Biol Res; 1983; 132E():3-10. PubMed ID: 6647472
    [No Abstract]   [Full Text] [Related]  

  • 14. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    Low E;
    J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary chemotherapy in cancer medicine. Proceedings of an International Symposium on Chemotherapy Preceding Surgery or Irradiation in Cancer Medicine. Valkenburg a/d Geul, The Netherlands, January 31-February 2, 1985.
    Prog Clin Biol Res; 1985; 201():1-403. PubMed ID: 4095104
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.
    Porter GA; Cantor SB; Walsh GL; Rusch VW; Leung DH; DeJesus AY; Pollock RE; Brennan MF; Pisters PW
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1366-72. PubMed ID: 15115994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of postoperative adjuvant chemotherapy on the immune system in 100 cancer patients.
    Israel L; Samak R; Grefft-Alami A; Edelstein R
    Prog Clin Biol Res; 1983; 132E():35-44. PubMed ID: 6647476
    [No Abstract]   [Full Text] [Related]  

  • 18. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes.
    Orr RK; Col NF; Kuntz KM
    Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of surgical oncology in the Czech Republic.
    Zaloudík J
    Acta Univ Palacki Olomuc Fac Med; 2000; 143():109. PubMed ID: 11144112
    [No Abstract]   [Full Text] [Related]  

  • 20. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis.
    Tirelli U; Berretta M; Bearz A; Carbone A
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1355-6. PubMed ID: 22195374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.